Literature DB >> 824045

Oral methoxsalen photochemotherapy of mycosis fungoides.

B A Gilchrest, J A Parrish, L Tanenbaum, H A Haynes, T B Fitzpatrick.   

Abstract

The cutaneous manifestations of mycosis fungoides have been successfully treated in nine patients for 16 to 28 months with oral methoxsalen and subsequent irradiation with longwave ultraviolet light. The efficacy of this therapy was confirmed in one patient, who showed complete clearing of generalized plaques after 1 month (12 treatments) except for a shielded control area which worsened during this period. Methoxsalen photochemotherapy may prove a valuable addition to therapies currently available for mycosis fungoides and may obviate some of the problems associated with conventional management of this disorder.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824045     DOI: 10.1002/1097-0142(197608)38:2<683::aid-cncr2820380210>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Photochemotherapy. A reappraisal of its use in dermatology.

Authors:  H Moseley; J Ferguson
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

2.  Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.

Authors:  Peter Wolf; Scott N Byrne; Alberto Y Limon-Flores; Gerald Hoefler; Stephen E Ullrich
Journal:  Exp Dermatol       Date:  2016-04-18       Impact factor: 3.960

3.  Decreased circulating E rosette forming cells in psoralen UVA treated patients.

Authors:  J P Ortonne; A L Claudy; A Alario; J Thivolet
Journal:  Arch Dermatol Res       Date:  1977-05-27       Impact factor: 3.017

Review 4.  [Treatment of mycosis fungoides and Sézary syndrome].

Authors:  J P Nicolay; C Assaf
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

5.  Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.

Authors:  Pablo Vieyra-Garcia; Regina Fink-Puches; Stefanie Porkert; Roland Lang; Sophie Pöchlauer; Gudrun Ratzinger; Adrian Tanew; Sylvia Selhofer; Sator Paul-Gunther; Angelika Hofer; Alexandra Gruber-Wackernagel; Franz Legat; Vijaykumar Patra; Franz Quehenberger; Lorenzo Cerroni; Rachael Clark; Peter Wolf
Journal:  JAMA Dermatol       Date:  2019-05-01       Impact factor: 10.282

6.  [Semen analysis under photochemotherapy (PUVA-therapy) (author's transl)].

Authors:  W B Schill; C Hofmann; G Plewig
Journal:  Arch Dermatol Res       Date:  1979-03-31       Impact factor: 3.017

7.  Photochemotherapy in mycosis fungoides.

Authors:  L Hodge; A P Warin; R W Gange; S Bleehen; D Vella Briffa
Journal:  Br Med J       Date:  1977-11-12

8.  The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides.

Authors:  Joyce W Hoot; Li Wang; Terry Kho; Oleg E Akilov
Journal:  J Dermatolog Treat       Date:  2017-08-29       Impact factor: 3.359

9.  Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.).

Authors:  J P Ortonne; A Claudy; A Alario; J Thivolet
Journal:  Arch Dermatol Res       Date:  1978-07-28       Impact factor: 3.017

10.  PUVA-therapy for alopecia areata. An investigative study.

Authors:  I Weissmann; C Hofmann; G Wagner; G Plewig; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.